cbdMD Inc
YCBD0.935USD
+0.075+8.72%
Fechamento 05/09, 16:00（ET）Cotações atrasadas em 15 min
5.18MValor de mercado
PerdaP/L TTM
Mais detalhes de cbdMD Inc Empresa
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Informações da empresa
Código da empresaYCBD
Nome da EmpresacbdMD Inc
Data de listagemNov 17, 2017
Fundado em2015
CEOMr. T. Ronan Kennedy
Número de funcionários42
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 17
Endereço8845 Red Oak Blvd
CidadeCHARLOTTE
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal28217-5593
Telefone17044453060
Sitehttps://www.cbdmd.com/
Código da empresaYCBD
Data de listagemNov 17, 2017
Fundado em2015
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
656.00
+23.54%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
549.00
+29.48%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Scott G. Stephen
Mr. Scott G. Stephen
Independent Chairman of the Board
Independent Chairman of the Board
656.00
+23.54%
Mr. Bakari T. Sellers
Mr. Bakari T. Sellers
Independent Director
Independent Director
549.00
+29.48%
Mr. T. Ronan Kennedy
Mr. T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
--
--
Mr. Bradley Whitford
Mr. Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Chief Accounting Officer, Treasurer, Company Secretary
--
--
Dr. Sibyl Swift
Dr. Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
--
--
Mr. William F. Raines, III
Mr. William F. Raines, III
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
E-commerce sales
3.95M
77.30%
Wholesale sales
1.16M
22.70%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
E-commerce sales
3.95M
77.30%
Wholesale sales
1.16M
22.70%
Acionista
Tempo de atualização: sáb, 10 de mai
Tempo de atualização: sáb, 10 de mai
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Porter (Jeffrey H)
0.80%
Coffman (Raymond Scott)
0.54%
Lambeth (Marianne)
0.52%
Connective Capital Management, LLC
0.13%
Raines (William F III)
0.11%
Other
97.89%
Estatísticas dos acionistas
Acionista
Proporção
Porter (Jeffrey H)
0.80%
Coffman (Raymond Scott)
0.54%
Lambeth (Marianne)
0.52%
Connective Capital Management, LLC
0.13%
Raines (William F III)
0.11%
Other
97.89%
Tipo
Acionista
Proporção
Individual Investor
2.02%
Hedge Fund
0.19%
Research Firm
0.06%
Investment Advisor/Hedge Fund
0.03%
Venture Capital
0.02%
Investment Advisor
0.01%
Other
97.66%
Participação acionária institucional
Tempo de atualização: qua, 5 de mar
Tempo de atualização: qua, 5 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
79
136.53K
1.53%
-32.92K
2024Q4
76
811.68K
23.02%
+42.15K
2024Q3
80
869.63K
30.51%
+134.84K
2024Q2
85
734.40K
27.03%
-50.91K
2024Q1
91
757.62K
28.39%
-18.50K
2023Q4
95
764.16K
29.72%
+83.63K
2023Q3
108
684.81K
27.23%
+10.72K
2023Q2
117
634.68K
40.66%
-58.78K
2023Q1
120
655.15K
47.20%
-12.99K
2022Q4
124
560.94K
41.64%
-98.77K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Coffman (Raymond Scott)
387.69K
6.19%
--
--
Feb 21, 2025
Lambeth (Marianne)
373.60K
5.97%
--
--
Feb 21, 2025
Connective Capital Management, LLC
89.22K
1.42%
--
--
Dec 31, 2024
Raines (William F III)
81.42K
1.3%
+1.00K
+1.24%
Feb 21, 2025
Virtu Americas LLC
45.65K
0.73%
+45.65K
--
Dec 31, 2024
Two Sigma Investments, LP
16.11K
0.26%
-5.95K
-26.98%
Dec 31, 2024
The Vanguard Group, Inc.
13.04K
0.21%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
11.20K
0.18%
--
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: ter, 6 de mai
Tempo de atualização: ter, 6 de mai
Nome
Proporção
AdvisorShares Pure Cannabis ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Amplify Seymour Cannabis ETF
0%
Cambria Cannabis ETF
0%
AdvisorShares Pure Cannabis ETF
Proporção0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Amplify Seymour Cannabis ETF
Proporção0%
Cambria Cannabis ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Data
Tipo
Proporção
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1
Apr 14, 2023
Merger
45<1